Current filters:


Popular Filters

1051 to 1075 of 1220 results

EC and Italian government seek to boost generic medicine use


The European Commission’s formal call last week on Italy to comply with European Union rules on…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPoliticsRegulation

EC closes procedural case against Servier


The European Commission said last Friday that it has closed an investigation into Fremch independent…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationServier

Department of Justice seeks permanent injunction against Ranbaxy


The US Department of Justice, on behalf of the Food and Drug Administration, has filed a consent decree…

Asia-PacificGenericsLegalNorth AmericaRanbaxy LaboratoriesRegulation

Kenya court set to deliver ruling on anti-counterfeit law


After almost three years of waiting since three petitioners living with HIV filed a constitutional petition…

GenericsLegalMarkets & MarketingPharmaceuticalRest of the World

Overview of biologic regulations in India


Currently, all biologics in India, including innovative and copy biologics are approved as new drugs,…


Actavis launches latanoprost generics in Europe


Iceland-based generic drugmaker Actavis says that it has launched latanoprost eye drops in seven major…

ActavisEuropeGenericsLatanoprost OphthalmicMarkets & MarketingOphthalmicsPfizerXalatan

Watson buys Strides Arcolab unit for A$375 million; 2011 results


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

The Medicines Co settles with APP over Angiomax


The Medicines Company (Nasdaq: MDCO) says that it has settled the law suits filed by company in the US…

AngiomaxAPP PharmaceuticalsCardio-vascularFresenius KabiGenericsLegalNorth AmericaPatentsPharmaceuticalThe Medicines Company

Significant advances in biosimilar medicines claimed for Iran


Iran is making significant advances in medicine production, especially in the fields of biosimilar and…

BiotechnologyGenericsMarkets & MarketingRest of the World

EMA starts review of Gilenya; guidance on biosimilar interferon beta


The European Medicines Agency has begun a review of the benefits and risks of Swiss drug major Novartis’…

BiotechnologyEuropeGenericsGilenyainterferon betaNeurologicalNovartisPharmaceuticalRegulation

Sandoz initiates two more Phase III biosimilar trials


Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX), says that it has initiated two milestone…


Mylan debuts innovative version of levetiracetam


US generic drugmaker Mylan (Nasdaq: MYL) says that its Mylan Institutional business has launched Levetiracetam…

GenericsKeppraLevetiracetamMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaUCB

Generics key to ensuring affordable Rx drugs in Australia


A new Australian government-funded survey into the increased use of medicines by an aging population…

Asia-PacificGenericsMarkets & MarketingPricing

India’s Dishman buys French company


Indian drugmaker Dishman Pharmaceuticals and Chemicals says that its Swiss unit has acquired a contract…

CréapharmGenericsMergers & Acquisitions

Fake drugs dashing hopes of controlling malaria in Africa


The emergence of fake and poor quality anti-malarial drugs could dash hopes of controlling malaria in…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldTropical diseases

Patent expiry of key blockbuster drugs good news for generics manufacturers, says F&S


The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing…

GenericsMarkets & MarketingPatentsPharmaceutical

FDA completes work on three drug user fee programs


The US Food and Drug Administration has completed its recommendations for three user fee programs that…

BiotechnologyFinancialGenericsNorth AmericaPharmaceuticalRegulation

A lot of user fee issues in USA


2012 has only just begun, but the US Congress, the Food and Drug Administration and several health care…

BiotechnologyGenericsNorth AmericaPharmaceuticalPoliticsRegulation

US ANDAs filed for generic Beyaz, Isentress and Epivir


The US Food and Drug Administration says that Abbreviated New Drug Applications have been received by…

Anti-viralsBayerBeyazEpivirGenericsGlaxoSmithKlineIsentressMerck & CoPharmaceuticalRegulationReproductive

Amerigen generics deal with Shanghai Fosun Omni


New Jersey, USA-based Amerigen Pharmaceuticals has entered into a collaboration agreement with China’s…

Amerigen PharmaceuticalsAsia-PacificFosun Omni PharmaGenericsLicensingResearch

Nipro Pharma to make generics in Vietnam


Earlier this week, Japan’s Nipro Corp announced that its subsidiary, Nipro Pharma, will set up a…


1051 to 1075 of 1220 results

Back to top